.
Dental Problems in Clinical Rheumatology
Study Course Description
Course Description Statuss:Approved
Course Description Version:4.00
Study Course Accepted:02.11.2021 14:59:30
Study Course Information | |||||||||
Course Code: | ISK_038 | LQF level: | Level 7 | ||||||
Credit Points: | 1.00 | ECTS: | 1.50 | ||||||
Branch of Science: | Clinical Medicine; Internal Medicine | Target Audience: | Dentistry | ||||||
Study Course Supervisor | |||||||||
Course Supervisor: | Vladimirs Voicehovskis | ||||||||
Study Course Implementer | |||||||||
Structural Unit: | Department of Internal Diseases | ||||||||
The Head of Structural Unit: | |||||||||
Contacts: | Riga, 2 Hipokrata Street, iskrsu[pnkts]lv, +371 67042338 | ||||||||
Study Course Planning | |||||||||
Full-Time - Semester No.1 | |||||||||
Lectures (count) | 2 | Lecture Length (academic hours) | 2 | Total Contact Hours of Lectures | 4 | ||||
Classes (count) | 6 | Class Length (academic hours) | 2 | Total Contact Hours of Classes | 12 | ||||
Total Contact Hours | 16 | ||||||||
Study course description | |||||||||
Preliminary Knowledge: | Normal anatomy, histology, normal physiology, biochemistry, basics of medical physics, biology and basics of genetics, microbiology/immunology, internal diseases propaedeutics, skin and mouth mucosa diseases, oral morphology. | ||||||||
Objective: | 1) To learn about the anamnesis compilation principles in determination or exclusion of rheumatologic diseases; 2) To learn the examination principles of peripheral joint and spine mobility; 3) To learn about the nature of a disease (pathogenesis, main mechanism, clinical manifestations), diagnostic (immunological analyses, radiological investigations) and therapy principles, prognosis; 4) To learn how to choose and interpret laboratory and instrumental investigation data, in case of various rheumatologic diseases; 5) To promote the development of students' clinical thinking. | ||||||||
Topic Layout (Full-Time) | |||||||||
No. | Topic | Type of Implementation | Number | Venue | |||||
1 | Rheumatological pathology reflections on the maxillofacial region. | Lectures | 1.00 | clinical base | |||||
2 | The profile of a rheumatologic patient; Autoimmune inflammatory arthritis; Crystal-induced arthropathy; Connective tissue diseases; Vasculitis. | Lectures | 1.00 | clinical base | |||||
3 | Working principles with rheumatologic patients in the practice of a physician and a dentist. | Classes | 1.00 | clinical base | |||||
4 | Working principles with patients suffering from arthritis. | Classes | 1.00 | clinical base | |||||
5 | Working principles with patients suffering from septic arthritis. | Classes | 1.00 | clinical base | |||||
6 | Working principles with patients suffering from arthropathy. | Classes | 1.00 | clinical base | |||||
7 | Working principles with patients suffering from connective tissue disease. | Classes | 1.00 | clinical base | |||||
8 | Working principles with patients suffering from vasculitis. | Classes | 1.00 | clinical base | |||||
Assessment | |||||||||
Unaided Work: | Acquisition of theoretical knowledge through scientific publications and literature, preparation of training materials for studies. The patient examination, analysis and interpretation of the investigation results, filling in the medical history. | ||||||||
Assessment Criteria: | Cumulative exam: – student present one Clinical case description (PowerPoint presentation, 10 – 15 min.) The student demonstrates understanding of the topics being presented and his ability to solve problems raised in real clinical situations - 60% from final grade; – student's activity during the course (taking part in discussions, questions, comments) - 40% from final grade. | ||||||||
Final Examination (Full-Time): | Exam | ||||||||
Final Examination (Part-Time): | |||||||||
Learning Outcomes | |||||||||
Knowledge: | • To collect targeted anamnesis, to list and describe the musculoskeletal physical examination principles, to define the possible diagnosis assessing treatment safety. • To define aspects of pathogenesis, diagnosis (classification and diagnostic criteria) and therapy principles of rheumatologic diseases. • To analyse the obtained information and to define the diagnosis, to assess disease activity and prognosis. • To do histological interpretation of biopsy results and to describe their application in dentist’s practice – aspects of cooperation with a rheumatologist. • To describe emergency and urgent situations for rheumatologic patients in dentist’s practice. | ||||||||
Skills: | The students are able to: • Communicate with patients, their relatives, co-workers and other persons involved in health care. • Collect a medical history. • Perform patient's physical examination. • Interpret laboratory and imaging results used in rheumatological practice. • Decide on treatment principles and therapeutic aspects of safety monitoring of rheumatological diseases. • Summarize the acquired symptoms and present the diagnosis and medical history. | ||||||||
Competencies: | • To evaluate the obtained medical history, physical findings and to determine the diagnosis and the differential diagnosis/es. • To assemble and justify the necessary laboratory and radiological examination plan for confirmation of the diagnosis and exclusion of the differential diagnosis. • To interpret laboratory and radiological examination results. • To be competent in pathogenesis, diagnosis, treatment principles and variations of rheumatologic diseases. • To be able to analyse situations, substantiate, logically formulate and explain own opinion. | ||||||||
Bibliography | |||||||||
No. | Reference | ||||||||
Required Reading | |||||||||
1 | Oxford Textbook of Rheumatology. Oxford University Press, 2013 | ||||||||
2 | Sterling G. West. Rheumatology Secrets; 2020 | ||||||||
3 | Atlas of Rheumatology (edited by Gene G. Hunder), 2009 (akceptējams izdevums) | ||||||||
Additional Reading | |||||||||
1 | Bioloģisko slimību modificējošo antireimatisko medikamentu lietošanas vadlīnijas autoimūno iekaisumu artrītu ārstēšanā pieaugušajiem. Darba grupas vadītāja prof. Daina Andersone, 2011. gads | ||||||||
2 | EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifyin antirheumatic drugs. J. Smolen et al. Ann Rheum Dis. 2010 Jun; 69(6): 964-75 | ||||||||
3 | EULAR recommendation for the management of early arthritis. Combe et al. Ann Rheum Dis 2007 Jan Vol. 66 No. 1, p. 34-45 | ||||||||
4 | EULAR evidence based recommendations for the management of hand osteoarthritis – report of a task force of the EULAR Standing Committee for the International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, Mar 2007; 66: 377 – 388. | ||||||||
5 | EULAR evidence based recommendations for the management of hip osteoarthritis – report of a task force of the EULAR Standing Committee for the International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, Oct 2004; 64: 669-681. | ||||||||
6 | EULAR recommendation 2003: an evidence based approach to the management of knee osteoarthritis – report of a task force of the EULAR Standing Committee for the International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, Jul 2003; 62: 1145-1155. | ||||||||
7 | The Assessment of Spondyloarthritis International Society (ASAS) Handbook: a guide to assess spondyloarthritis. Siper J. et al. Ann Rheum Dis 2009; 68, suppl. 2. | ||||||||
8 | 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2011; 70:905-908. | ||||||||
9 | EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis 2012;71: 4-12. | ||||||||
10 | EULAR evidence based recommenations for gout. Part I: Diagnosis. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis Oct, 2006; 65: 1301-1311. | ||||||||
11 | EULAR evidence based recommenations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis May, 2006; 65: 1312-1324. | ||||||||
12 | EULAR recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis 2011; 70: 563-570. | ||||||||
13 | EULAR recommendations for calcium pyrophosphate deposition. Part II: mangement. Ann Rheum Dis 2011; 70: 571-575. | ||||||||
14 | Joint EULAR and European Renal Association- European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis, published 31 July 2012 | ||||||||
15 | EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic disease. Ann Rheum Dis 2011; 70: 414-422. | ||||||||
16 | EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a tas force of the EULAR standing committee for clinical affairs. Ann Rheum Dis, 19 August 2010, online published | ||||||||
17 | EULAR recommendations for the treatment of systemic sclerosis: a repot task from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis, Jan 2009; 68: 620-628 | ||||||||
18 | EULAR points to consider in the development of classification and diagnostic criateria in systemic vasculitis. Ann Rheum Dis 2010; 69:1744-1750 | ||||||||
19 | EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, Feb 2008; 67: 195 – 205. | ||||||||
Other Information Sources | |||||||||
1 | http://www.asas-group.org/ | ||||||||
2 | www.eular.com | ||||||||
3 | http://www.rheumatology.org/Practice/Clinical/Clinical_Supp… |